1-5 of 5
Authors: Kurt Hertogs
Journal Article
Long-Cycle Structured Intermittent versus Continuous Highly Active Antiretroviral Therapy for the Treatment of Chronic Infection with Human Immunodeficiency Virus: Effects on Drug Toxicity and on Immunologic and Virologic Parameters Get access
The Journal of Infectious Diseases, Volume 188, Issue 3, 1 August 2003, Pages 388–396, https://doi.org/10.1086/376535
Published: 01 August 2003
Journal Article
Despite High Concordance, Distinct Mutational and Phenotypic Drug Resistance Profiles in Human Immunodeficiency Virus Type 1 RNA Are Observed in Gastrointestinal Mucosal Biopsy Specimens and Peripheral Blood Mononuclear Cells Compared with Plasma Get access
The Journal of Infectious Diseases, Volume 183, Issue 1, 1 January 2001, Pages 143–148, https://doi.org/10.1086/317640
Published: 01 January 2001
Journal Article
Evaluation of Lymph Node Virus Burden in Human Immunodeficiency Virus—Infected Patients Receiving Efavirenz-Based Protease Inhibit—Sparing Highly Active Antiretroviral Therapy Get access
The Journal of Infectious Diseases, Volume 181, Issue 4, April 2000, Pages 1273–1279, https://doi.org/10.1086/315407
Published: 01 April 2000
Journal Article
Resistance Profiles in Patients with Viral Rebound on Potent Antiretroviral Therapy Get access
The Journal of Infectious Diseases, Volume 181, Issue 3, March 2000, Pages 1143–1147, https://doi.org/10.1086/315301
Published: 01 March 2000
Journal Article
Dual Resistance to Zidovudine and Lamivudine in Patients Treated with Zidovudine-Lamivudine Combination Therapy: Association with Therapy Failure Get access
The Journal of Infectious Diseases, Volume 177, Issue 6, June 1998, Pages 1521–1532, https://doi.org/10.1086/515304
Published: 01 June 1998
